Work

Hypersensitivity to the CGRP Inhibitor Monoclonal Antibodies Galcanezumab, Erenumab, and Fremanezumab With Tolerance to Eptinezumab

Year: 2024

Type: article

Source: Journal of Investigational Allergology and Clinical Immunology

DOI: 10.18176/jiaci.1000

Authors: B Barroso, JM Rodrigo-Muñoz, M Gil-Martínez, V del Pozo, J Rodríguez-Vico, D Betancor, M Valverde-Monge, A Gómez-López, J Sastre

Institutions: Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Hospital Universitario Fundación Jiménez Díaz

Language: English

Topic: Drug-Induced Adverse Reactions

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: diamond

OpenAlex ID: W4403640132

FWCI:

Cites:

Cited by:

Related to: 10